Skip to Main Content Menu Search Site

HarborSite: Precise and Efficient Gene Editing for Next-Generation Gene Therapies

Integration of therapeutic genes into genomic safe harbors using highly specific and efficient recombinases could enable more predictable, safe, and durable gene therapies

Interested in this technology?

The HarborSite team is currently seeking partners and collaborators to help commercialize this technology.


Synthetic Biology

Technology Development Team
Key Features
  • Integration of genes into genomic safe harbor (GSH) sites ensures their safe and prolonged expression
  • Recombinase enzymes (recombinases) enable precise and efficient genome integration of large therapeutic gene sequences
  • HarborSite platform enables safe and durable gene and cell therapies for diseases of liver, blood, lung, skin, and other tissues
Close menu